RNS Number : 4647M Renalytix PLC 29 April 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: Icahn

RNS Number : 3854M Stifel Nicolaus Europe Limited 29 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

RNS Number : 2850M Renalytix PLC 29 April 2024   Renalytix plc ("Renalytix" or the "Company")   Admission of the First Tranche Placing Shares   LONDON and SALT LAKE CITY -   29 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)   confirms that, further to the announcements made on 12 March

RNS Number : 2943M Renalytix PLC 26 April 2024   S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares: Renalytix PLC 1b. Please indicate if the issuer is a non- UK issuer    (please mark with an "X"

RNS Number : 2828M Lombard Odier Asset Mgt (Eur) Ltd. 26 April 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of

RNS Number : 2815M Renalytix PLC 26 April 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing

RNS Number : 2067M Stifel Nicolaus Europe Limited 26 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.            KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of

RNS Number : 2276M Polar Capital Holdings PLC 26 April 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of

RNS Number : 0845M Renalytix PLC 25 April 2024   Renalytix plc ("Renalytix" or the "Company")   Allotment and issue of the Second Tranche Placing Shares Rule 2.9 Announcement   LONDON and SALT LAKE CITY -   25 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)   confirms that the Second